Concepedia

Author

Kenshi Kamei

Chugai Pharma (United States)

Also Known As

Kenshi Kamei

20

Publications

286

Citations

9

H-Index

15

Concepts

All Affiliations

Chugai Pharma (United States)Gunma UniversityKitasato Institute HospitalKU Leuven
KK

About

Kenshi Kamei is an author at Chugai Pharma (United States) specializing in medicine, pharmacotherapy, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

200

2

Natural Sciences

2

2

119

3

Biochemistry

2

2

119

4

Gastroenterology

2

2

56

5

Anesthesia

1

1

23

Kenshi Kamei

×

9

Publications

258

Citations

9

H-Index

YearCitations

Novel antiasthmatic agents with dual activities of thromboxane A2 synthetase inhibition and bronchodilation. 1. 2-[2-(1-Imidazolyl)alkyl]-1(2H)-phthalazinones

M. YAMAGUCHI, Kenshi Kamei, Takaki Koga,

Journal of Medicinal Chemistry

1993

91

An orally active motilin receptor antagonist, MA-2029, inhibits motilin-induced gastrointestinal motility, increase in fundic tone, and diarrhea in conscious dogs without affecting gastric emptying

Kenichi Ozaki, Mitsu Onoma, Hiroyasu Muramatsu,

European Journal of Pharmacology

2009

33

Novel antiasthmatic agents with dual activities of thromboxane A2 synthetase inhibition and bronchodilation. 2. 4-(3-Pyridyl)-1(2H)-phthalazinones

M. YAMAGUCHI, Kenshi Kamei, Takaki Koga,

Journal of Medicinal Chemistry

1993

28

Oral administration of MA-2029, a novel selective and competitive motilin receptor antagonist, inhibits motilin-induced intestinal contractions and visceral pain in rabbits

Hirokazu Sudo, Shoshin Yoshida, Kenichi Ozaki,

European Journal of Pharmacology

2007

25

Effects of Mitemcinal (GM-611), an Acid-Resistant Nonpeptide Motilin Receptor Agonist, on the Gastrointestinal Contractile Activity in Conscious Dogs

Kenichi Ozaki, Kenji Yogo, Hirokazu Sudo,

Pharmacology

2007

23

ORAL MITEMCINAL (GM‐611), AN ERYTHROMYCIN‐DERIVED PROKINETIC, ACCELERATES NORMAL AND EXPERIMENTALLY DELAYED GASTRIC EMPTYING IN CONSCIOUS DOGS

Mitsu Onoma, Kenji Yogo, Kenichi Ozaki,

Clinical and Experimental Pharmacology and Physiology

2007

18

Regional and species differences in glyburide‐sensitive K<sup>+</sup>channels in airway smooth muscles as estimated from actions of KC 128 and levcromakalim

Kenshi Kamei, Shohshin Yoshida, Jun‐ichi Imagawa,

British Journal of Pharmacology

1994

15

Hemodynamic and Hormonal Responses to Nicorandil in a Canine Model of Acute Ischemic Heart Failure: A Comparison with Cromakalim and Nitroglycerin

Takeshi Kamijo, Kenshi Kamei, Izumi Sugo,

Journal of Cardiovascular Pharmacology

1999

13

MITEMCINAL (GM‐611), AN ORALLY ACTIVE MOTILIN RECEPTOR AGONIST, IMPROVES DELAYED GASTRIC EMPTYING IN A CANINE MODEL OF DIABETIC GASTROPARESIS

Mitsu Onoma, Kenichi Ozaki, Kenji Yogo,

Clinical and Experimental Pharmacology and Physiology

2008

12

Page 1